The term “key opinion leaders” derives from the work of Sociologist Paul Lazarfeld and his team on the behavioural pattern in politics, fashion, culture, medicine and other domains.
On the marketing efforts, the Pharma and Biotech industry often develops and turns to “key Opinion leaders”, typically referred as KOLs to disseminate the scientific information and drug innovations with their peers, which is fundamental for the continued improvement of patient treatment and health outcomes
Key Opinion Leaders are the key to successful brand marketing, so identifying and engaging them is big business. Researching Global Medical Experts is our key specialization gained by executing more than 300 KOL projects covering 25+ different therapeutic areas across the globe. We support healthcare companies as well as agencies providing KOL & Medical communication services in understanding Global Key Opinion Leaders.
Our targeted approach to KOL identification and influence mapping optimizes your spend and yields more actionable data faster and reliable.
Today’s Market has become very competitive and need for a KOL/Thought Leader have become an imperative for any brand’s strategy.
D2L has been involved in identifying the influential leaders/thought leaders across the globe and identifying renowned KOLs requires less than 50 percent of the time, but National and International KOLs are not uncovered as these individuals do not typically write prescriptions but are busy developing guidelines, investigating research activity and conducting speaking tours. Our identification methodology can segment the Leaders by geographic influence, experience and activity level to yield the broadest possible coverage in pertinent therapeutic categories thereby targeting product adoption and advocacy.
Our team of experts carry experience in identifying right physician/thought leader to your specific needs, we have developed different tools and applications to gather the information related to Publications, Clinical trials, guidelines and speaking engagements to reduce the time and efforts. Our geographic focus is not limited to only US, 5 EU and Japan markets, our local language expertise have value addition when it comes to non English speaking countries like China, Thailand, Vietnam, Russia, Latin America, Brazil etc. We have researched and ranked more than 80,000 experts across several therapeutic areas and disease states at competitive pricing, quick turn around and thereby maintaining the quality standards.
D2L Pharma Advantage
Extensive experience in identifying and profiling of KOLs across a wide range of therapeutic categories
Global database of large directories of clinical trial researchers, publicists,HCPs,and speakers
High value, with quality results in shorter time
Extreme flexibility – we mobilize rapidly for projects